On the contrary, however, inhibition of the IGF1R signaling pathway using an IGF1R-specific antibody is reported to enhance NK cell expansion following their activation and to maintain their potent cytotoxic activity in vitro against Ewing sarcoma (64). This evidence concerns the gene IGF1R and Ewing sarcoma.